Relationship between exposure to the pesticide Rotenone and the development of motor and non-motor symptoms of Parkinson's disease
DOI:
https://doi.org/10.33448/rsd-v9i9.7917Keywords:
Pesticides; Nervous system diseases; Gastrointestinal tract; Parkinson disease.Abstract
Introduction: Parkinson's disease (PD) is known for its debilitating motor symptoms and the dependence that its progression causes. Although classic, this condition still does not have its causal factors fully elucidated and, therefore, the prediction sometimes becomes ineffective. In the search for a better understanding of the disease, researchers found an intimate relationship between their symptoms and populations that had contact with the pesticide rotenone, widely used in agricultural processes and that can be an auxiliary factor in the development of the disease in the agricultural population. Objective: To elucidate, based on the literature, the interrelation of Parkinson's Disease with rotenone. Methodology: Integrative literature review that used the descriptors: “Parkinson Disease”, “Rotenone”, “Synucleins”, “Gastrointestinal Tract”, “Vagus Nerve” and “Microbiota” in the databases: PubMed, ScienceDirect, SCIELO, and BVS where 13 documents were selected for analysis that elucidated in their text the relationship between the disease and the substance studied. Results: The works portray an intimate relationship between exposure to rotenone and non-motor symptoms of Parkinson's disease. Also, these symptoms mainly affect signs in the gastrointestinal tract, which sometimes can help in the prediction of the disease long before the manifestation of classic symptoms. Final Considerations: Rotenone has a well-elucidated relationship in the development of Parkinson's disease, besides, this relationship allows a better understanding of the connection between the brain and the gastrointestinal tract through the vagus nerve. Thus, such findings can serve as a basis for a better understanding and prevention of the diagnosis and treatment of PD.
References
Arnhold, M., Dening, Y., Chopin, M., Arévalo, E., Schwarz, M., & Reichmann, H. et al. (2016). Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson’s disease. Clinical Autonomic Research, 26(3), 211-222. https://doi.org/10.1007/s10286-016-0358-6
Baizabal-Carvallo, J., & Alonso-Juarez, M. (2020). The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease. Neuroscience, 432, 160-173. https://doi.org/10.1016/j.neuroscience.2020.02.030
Bu, J., Qiao, X., He, Y., & Liu, J. (2019). Colonic electrical stimulation improves colonic transit in rotenone-induced Parkinson's disease model through affecting enteric neurons. Life Sciences, 231, 116581. https://doi.org/10.1016/j.lfs.2019.116581
Dantas, É., & Ramalho, D. (2020). O uso de diferentes metodologias no ensino de microbiologia: Uma revisão sistemática de literatura. Research, Society And Development, 9(8), e665986396. https://doi.org/10.33448/rsd-v9i8.6396
Drolet, R., Cannon, J., Montero, L., & Greenamyre, J. (2009). Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology. Neurobiology Of Disease, 36(1), 96-102. https://doi.org/10.1016/j.nbd.2009.06.017
Johnson, M., Stringer, A., & Bobrovskaya, L. (2018). Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson’s disease. Neurotoxicology, 65, 174-185. https://doi.org/10.1016/j.neuro.2018.02.013
Kim, S., Kwon, S., Kam, T., Panicker, N., Karuppagounder, S., & Lee, S. et al. (2019). Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease. Neuron, 103(4), 627-641.e7. https://doi.org/10.1016/j.neuron.2019.05.035
Klingelhoefer, L., & Reichmann, H. (2015). Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors. Nature Reviews Neurology, 11(11), 625-636. https://doi.org/10.1038/nrneurol.2015.197
Klingelhoefer, L., & Reichmann, H. (2017). The Gut and Nonmotor Symptoms in Parkinson's Disease. International Review Of Neurobiology, 787-809. https://doi.org/10.1016/bs.irn.2017.05.027
Koutzoumis, D., Vergara, M., Pino, J., Buddendorff, J., Khoshbouei, H., Mandel, R., & Torres, G. (2020). Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease. Experimental Neurology, 325, 113159. https://doi.org/10.1016/j.expneurol.2019.113159
Martinez, E., Young, A., Patankar, Y., Berwin, B., Wang, L., & von Herrmann, K. et al. (2017). Editor’s Highlight: Nlrp3 Is Required for Inflammatory Changes and Nigral Cell Loss Resulting From Chronic Intragastric Rotenone Exposure in Mice. Toxicological Sciences, 159(1), 64-75. https://doi.org/10.1093/toxsci/kfx117
Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., & Petticrew, M. et al. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews, 4(1). https://doi.org/10.1186/2046-4053-4-1
Pan-Montojo, F., & Funk, R. (2010). Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System. Journal Of Visualized Experiments, (44). https://doi.org/10.3791/2123
Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., & Jung, R. et al. (2010). Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice. Plos ONE, 5(1), e8762. https://doi.org/10.1371/journal.pone.0008762
Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G., & Pal, A. et al. (2012). Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Scientific Reports, 2(1). https://doi.org/10.1038/srep00898
Perez-Pardo, P., Dodiya, H., Broersen, L., Douna, H., van Wijk, N., & Lopes da Silva, S. et al. (2017). Gut–brain and brain–gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet. Nutritional Neuroscience, 21(6), 391-402. https://doi.org/10.1080/1028415x.2017.1294555
Perez-Pardo, P., Dodiya, H., Engen, P., Naqib, A., Forsyth, C., & Green, S. et al. (2018). Gut bacterial composition in a mouse model of Parkinson’s disease. Beneficial Microbes, 9(5), 799-814. https://doi.org/10.3920/bm2017.0202
Sharma, S., Awasthi, A., & Singh, S. (2019). Altered gut microbiota and intestinal permeability in Parkinson’s disease: Pathological highlight to management. Neuroscience Letters, 712, 134516. https://doi.org/10.1016/j.neulet.2019.134516
Spielman, L., Gibson, D., & Klegeris, A. (2018). Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases. Neurochemistry International, 120, 149-163. https://doi.org/10.1016/j.neuint.2018.08.005
Tanner, C., Kamel, F., Ross, G., Hoppin, J., Goldman, S., & Korell, M. et al. (2011). Rotenone, Paraquat, and Parkinson’s Disease. Environmental Health Perspectives, 119(6), 866-872. https://doi.org/10.1289/ehp.1002839
Tasselli, M., Chaumette, T., Paillusson, S., Monnet, Y., Lafoux, A., & Huchet-Cadiou, C. et al. (2013). Effects of oral administration of rotenone on gastrointestinal functions in mice. Neurogastroenterology & Motility, 25(3), e183-e193. https://doi.org/10.1111/nmo.12070
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Jennifer Kelly Silva de Oliveira; Jociele Moreira de Carvalho; Camila Alexandre Silva; Mateus Barbosa de Lima; Paulo Matheus Freitas Cavalcante; Daniel Felipe Fernandes Paiva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
